of CPZ were detected in the stools when an oral dose was added, 1,446 to 5,445 ,ug/ml, and the bacterial counts were reduced maximally 4 to 6 loglo CFU/g. The combination of the oral and intravenous doses produced suppression of the microflora and high levels in blood, all with a single antibiotic.
The most widely accepted form of antimicrobial prophylaxis for elective colorectal surgery in the United States is the combination of oral neomycin-erythromycin in a threedose schedule, administered at 1, 2, and 11 p.m. the day before surgery (16) . It is becoming commonplace to combine this oral regimen with a parenteral cephalosporin antibiotic in order to provide levels of antibiotic in blood and enhance systemic protection. Some studies have suggested that the third drug, usually a cephalosporin with activity against Bacteroides fragilis, provides protection superior to that provided by the oral drugs alone (6, 18) . This point remains controversial, however, because postoperative infection rates in the groups receiving the oral preparation alone are usually higher (-15%) than those reported in the earlier large-scale Veterans Administration cooperative studies that established the efficacy of the neomycin-erythromycin preparation (6 to 9%) (5) .
The rationale for the oral antibiotic bowel preparation is suppression of the intestinal microflora so that any leakage of luminal contents would contain a low inoculum of microorganisms (19) . The parenteral antibiotic is thought to add another barrier to tissue invasion by organisms in the microflora by creating a level of antibiotic in blood.
In addition to the antimicrobial regimen, mechanical cleansing is of fundamental importance in reducing the bacterial burden. However, in patients who are operated on urgently or who have bowel obstruction, it may not be possible to effect mechanical cleansing or to administer an oral regimen, and the main burden for prophylaxis in these high-risk patients falls upon the parenterally administered drug(s). Despite the preliminary evidence that there is a benefit from concomitant oral and parenteral antibiotics in prophylaxis for bowel surgery, there are clear concerns about such an approach from the aspects of drug toxicity, antibiotic resistance, and cost (19) . Thus, there would be considerable interest in a regimen which meets the same objectives with a single drug.
MATERIALS AND METHODS
Subjects. Twenty-four healthy males, ages 20 to 40 years, were studied. They underwent a complete physical examination and routine laboratory tests including complete blood cell count and differential, serum glutamic oxalacetic transaminase, lactate dehydrogenase, prothrombin time, bilirubin, alkaline phosphatase, and urinalysis. No antibiotics had been taken for 1 month preceding the study. Written informed consent was obtained, and the volunteers were admitted to the Clinical Study Unit (New England Medical Center, Boston, Mass.) for 36 h.
Treatment. On day 1, a standard mechanical bowel preparation was administered. Subjects were given 4 liters of an intestinal lavage solution (Golytely) orally over a period of 4 h, until clear fecal effluent was obtained. They were assigned to receive either cefoperazone (CPZ), neomycin-erythromycin (1 g of each at 1, 2, and 11 p.m.), or no antibiotics. Sixteen volunteers received CPZ. They were divided into three groups: group 1 (n = 8) received 3 doses (range, 3 to 6 g) of intravenous (i.v.) CPZ, group 2 (n = 4) received i.v. cefoperazone plus a gallbladder stimulant (high-fat emulsion), and group 3 (n = 4) was given both parenteral and oral CPZ (2 doses of 1 g each) with high-fat emulsion. The oral dose of CPZ was given in 50 ml of sodium bicarbonate. These regimens are listed in Table 1 . Day 2 represented the proposed day of surgery.
Microbiological studies. Stool samples were collected in sterile plastic containers before treatment and on days 2, 3, and 8 after the antibiotic was received. Samples were immediately transported to an anaerobic chamber (Coy Laboratory Products, Ann Arbor, Mich.), and 0.5 g of stool was mixed in 4.5 ml of prereduced phosphate-buffered saline with 1% gelatin. Serial 10-fold dilutions were made, and 0.1-ml portions were plated on various media, as follows: anaerobic blood agar, total and facultative anaerobes; laked kanamycin-vancomycin, Bacteroides cultures of C. difficile were tested for cytotoxin by a tissue culture assay with neutralization by specific antitoxin (4) .
Drug levels. Serum samples were collected 1 h after the last dose of i.v. CPZ. Levels of CPZ in serum and stool were determined by a microbiological assay. Escherichia coli MOX was grown in Mueller-Hinton broth for 4 to 5 h at 37°C. The turbidity was adjusted to a 0.5 McFarland standard (approximately 108 CFU/ml), and 0.5 ml of the culture was added to molten Trypticase soy agar. Plates were allowed to solidify, and 4-mm wells were cut into the agar. A set of CPZ standards was prepared in phosphate-buffered saline with a concentration range of 2 to 512 ,ug/ml. The lowest level of CPZ that could be accurately detected was 2 ,ug/ml. The wells were filled with either serum, stool (1:10 dilution), or the standards. Zones of inhibition were read with a caliper after 18 to 24 h of aerobic incubation at 37°C. The standards were plotted on a graph (zone size versus concentration), and the samples were compared.
RESULTS
The total fecal bacterial counts before treatment (day 1) and after treatment (days 2 and 3) are listed in Table 2 . On day 2, the subjects given i.v. CPZ had 6.7 loglo CFU of Bacteroides spp. per g and 3.0 loglo CFU of enteric bacteria per g; this represents a reduction of 3.2 loglo CFU/g (Bacteroides spp.) and 4.2 loglo CFU/g (enteric organisms) from pretreatment levels (Fig. 1) . When the high-fat emulsion was added to the i.v. CPZ, the mean count of Bacteroides spp. was 5.1 log1o CFU/g and that of enteric bacteria was 4.2 log1o CFU/g (mean reductions of 4.8 and 3.0 log1o CFU/g, respectively). With these two regimens, the greatest reductions occurred on day 3, when the mean bacterial counts ranged from 2.0 to 4.1 loglo CFU/g (Bacteroides spp.) and <2.0 to 3.0 loglo CFU/g (enteric species). However, when the oral dose was added to i.v. CPZ, the mean counts dropped even further on day 2: 3.2 loglo CFU/g for Bacteroides spp. and 3.0 loglo CFU/g for enteric bacteria (Fig. 1) . Subjects receiving neomycin-erythromycin had total counts of <2.0 loglo CFU of Bacteroides spp. per g and <2.0 log 10 CFU of enteric bacteria per g on day 2.
Emergence of resistant organisms such as Pseudomonas spp., enterococci, Staphylococcus spp., and yeasts was not The concentrations of CPZ in stools are shown in Table 3 . On day 2, the volunteers who received i.v. CPZ had levels of drug in stool that ranged from <2 to 1,543 ,ug/ml (one subject). Those concentrations increased when the high-fat emulsion was added (105 to 649 ,ug/ml), but the highest concentrations were achieved after oral doses of CPZ were added (1,446 to 5,445 ,ug/ml). Fecal concentrations of CPZ were higher on day 3 than on day 2 for the groups that received i.v. CPZ alone or with high-fat emulsion (<2 to 2,656). The pattern was somewhat different in the group receiving i.v. plus oral CPZ in that the fecal concentrations peaked on day 2 and declined on day 3. DISCUSSION CPZ is a semisynthetic piperazine antibiotic which is excreted mainly through the biliary tract (14) . The drug has been reported to have a major impact on the composition of the bacterial fecal flora (1, 8, 13 ), probably because of its high biliary excretion. The majority of those studies, however, involved treatment with CPZ for at least a week.
In this study we gave only three doses of the drug to healthy volunteers. Immediately after the last i.v. dose the levels of drug in the stools were rather low. With the addition of high-fat emulsion, which emptied the gallbladder, fecal levels were somewhat higher. There was a remarkable increase when an oral dose of drug was added. Indeed, the i.v. and oral regimen produced the highest levels of drug in stool (1,446 to 5,445 pug/ml), and the fecal flora was maximally suppressed.
These findings suggest that the biliary excretion of i.v. CPZ was delayed, perhaps because of trapping of drug in the gallbladder. Emptying the gallbladder with high-fat emulsion did cause excretion of drug into the bowel, and high fecal levels were achieved 48 h after the last dose. Before that time, fecal levels of the drug were not high enough to produce major changes in the bacterial flora. For this reason, we gave a dose of CPZ by mouth. Since the drug is not absorbed from the intestine (9), high concentrations are produced in the feces, causing a major reduction in fecal flora within 12 h. This maneuver was successful in suppressing the flora at the time of the proposed surgery, at 8:00 a.m. on day 2.
Suppression of the fecal flora is related to two properties of CPZ. The biliary tract is a major route of excretion, and once in the intestine, CPZ is stable to most of the 3-lactamases produced by bacteria in the fecal flora (10, 15, 17) .
Many other broad-spectrum antibiotics have been evaluated as single prophylactic agents in colorectal surgery, for example, piperacillin and metronidazole, among others (7, 11) . In a limited trial, piperacillin was efficacious. i.v. metronidazole also showed good results, but its lack of activity against aerobic and facultative bacteria generally requires the addition of a second drug (19) .
Previous studies have reported the emergence of potential pathogens after prophylaxis or treatment with broad-spectrum antibiotics, including Pseudomonas spp., Staphylococcus spp., yeasts, enterococci, and clostridia (12) . We found that fecal counts of enterococci were elevated in the neomycin-erythromycin group, and yeasts were seen in one of the CPZ groups.
We recovered C. difficile from the feces of 10 of 16 subjects 7 days after the last dose of CPZ. However, none of the subjects complained of diarrhea, nausea, or cramps, and toxin titers were negative in their stools. C. difficile has been recovered even after a single dose of some antibiotics (2). Viscidi et al. found that 20 to 30% of adults were colonized with C. difficile after receiving antibiotics (20) .
The neomycin-erythromycin regimen remains the preferred preoperative bowel preparation for elective colorectal surgery. It achieved the most consistent suppression of the microflora on the planned day of surgery of all the regimens tested (day 2) (Table 2), thereby confirming the results of previous studies (3, 16 
